Highly protective E2–CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goats
- 1 February 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Biotechnology
- Vol. 133 (3), 370-376
- https://doi.org/10.1016/j.jbiotec.2007.09.014
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Marker vaccine strategies and candidate CSFV marker vaccinesVaccine, 2007
- High-level expression of human lactoferrin in the milk of goats by using replication-defective adenoviral vectorsProtein Expression and Purification, 2006
- Use of adenoviral vectors as veterinary vaccinesGene Therapy, 2005
- Origin and evolution of viruses causing classical swine fever in CubaVirus Research, 2005
- A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challengeVaccine, 2005
- Hormonal induced lactation in transgenic goatsAnimal Biotechnology, 2000
- Molecular epidemiology of classical swine fever in CubaVirus Research, 1999
- Transgenically Produced Human Antithrombin: Structural and Functional Comparison to Human Plasma–Derived AntithrombinBlood, 1998
- The Mammary Gland as a Bioreactor: Expression, Processing, and Production of Recombinant ProteinsJournal of Mammary Gland Biology and Neoplasia, 1998
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977